Gregg Popovich 911 call reveals distressing moment legendary NBA coach was 'barely responding'
TMZ revealed details of the panicked call made by a man at Ruth's Chris Steak House in San Antonio on April 15.
The former Spurs coach, 76, was rushed to hospital after the incident which occurred just six months after he had a mild stroke.
Worrying footage later emerged of the five-time NBA champion lying on a stretcher and being placed into an ambulance after reportedly fainting.
In the audio, you can hear the man tell the 911 operator that Popovich, who he didn't identify, had just passed out.
Describing Popovich as a 'guest', the man said he was 'non-responding' before later changing his phrasing to 'barely responding.'
Moments later, he noted that Popovich was starting to come around.
'Ok. He's responding now,' the man says. 'He passed out for a little bit.'
Popovich suffered a stroke before the Spurs-Timberwolves game on November 2 and was replaced by Mitch Johnson for the final 77 games of the season.
He left fans concerned in recent weeks when he made his first public appearance in six months.
As Johnson was formally introduced as the team's new head coach, Popovich - who will be moving upstairs to the role of team president - revealed a shirt reading 'El Jefe' as he displayed his trademark wit.
But Popovich still showed some signs of his health issues, as he grabbed onto his former player Manu Ginobili at one point when turning around, while another one of his ex-Spurs stars, Tim Duncan, carried a cane for him.
He also spoke far more softly than he has in the past, as he said his health was improving.
Popovich, who has more wins than any other coach in the history of the NBA, led Team USA to Olympic gold at the 2020 Tokyo games.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
3 minutes ago
- Reuters
Report: Browns QB Kenny Pickett injured during practice
July 27 - Cleveland Browns quarterback Kenny Pickett reportedly went down with a hamstring injury during Saturday's training camp session, casting uncertainty over his early momentum in a crowded quarterback competition. Sources told ESPN that Pickett sustained the injury while rolling to his right and throwing a touchdown during the final red zone drill of the day. The severity of the injury remains unclear and the Browns reportedly expect to re-evaluate him later this week. Pickett had been making a strong case to become the Browns' starter, taking a majority of the first-team reps during the opening week of training camp. Browns quarterbacks coach Bill Musgrave described his performance in the first two practices as "stellar," particularly praising his accuracy. Pickett's early success had seemingly put him ahead in the four-man competition, which includes veteran Joe Flacco and rookies Dillon Gabriel and Shedeur Sanders. The injury now opens the door for the remaining quarterbacks to gain valuable reps. Flacco, entering his 18th NFL season, has rotated with Pickett throughout camp and brings veteran leadership to the position group. Gabriel, a third-round pick out of Oregon, has had limited time with the first team, while Sanders, a fifth-round pick from Colorado, has yet to take any first-team snaps. Pickett, a 2022 first-round pick by the Pittsburgh Steelers, was traded to the Browns in March by the Philadelphia Eagles. Cleveland gave up a fifth-round pick and young quarterback Dorian Thompson-Robinson in the deal. With the Browns declining his fifth-year option, Pickett is set to become a free agent after the 2025 season. --Field Level Media
The Independent
32 minutes ago
- The Independent
Bubba Wallace wins Brickyard 400 to become Indy's first Black winner
Bubba Wallace became the first Black driver to win on Indianapolis Motor Speedway's 2.5-mile oval, surviving a late rain delay, two overtimes, concerns over running out of fuel and a hard-charging Kyle Larson on Sunday in the Brickyard 400. The third NASCAR Cup victory of Wallace's career was also his biggest. It snapped a 100-race winless streak that dated to 2022 at Kansas. He also won at Talladega in 2021. It's his first win at one of NASCAR's four crown jewel races. 'Unbelievable,' Wallace shouted on his radio after crossing the yard of bricks. And while the final gap was 0.222 seconds, he didn't reach victory lane without some consternation. Larson trailed by 5.057 seconds with 14 laps to go but the gap was down to about three seconds with six remaining when the yellow flag came out because of rain. The cars rolled to a stop on pit lane with four to go, giving Wallace about 20 additional minutes to think and rethink his restart strategy. But after beating Larson through the second turn, a crash behind the leaders forced a second overtime, extending the race even more laps as Wallace's team thought he might run out of gas. Wallace risked everything by staying on the track then beat the defending race winner off the restart again to prevent Larson from becoming the fourth back-to-back winner of the Brickyard. It also alleviated the frustration Wallace felt Saturday when he spent most of the qualifying session on the provisional pole only to see Chase Briscoe surpass with one of the last runs in the session. He made sure there was no repeat Sunday, giving an added boost to the 23XI Racing co-owned by basketball Hall of Famer Michael Jordan and last week's race winner, Denny Hamlin, as it continues to battle NASCAR in court over its charter status. ___
Reuters
33 minutes ago
- Reuters
Roche to investigate whether new drug can delay or prevent Alzheimer's disease
July 27 (Reuters) - Swiss drugmaker Roche Holding (ROG.S), opens new tab plans to investigate whether an experimental medicine can delay or prevent Alzheimer's disease symptoms, it said on Sunday, as a part of the company's growing development programme for the disease. The clinical trial of the drug, Trontinemab, will target people who are at risk of cognitive decline and will aim to delay or prevent the symptoms of Alzheimer's, Roche said in a statement. Trontinemab is designed so that the drug is transported across the blood brain barrier—protective blood vessels that prevent chemicals in the bloodstream from entering the brain — in hopes of delivering more of the treatment to the brain. Rivals like Eli Lilly (LLY.N), opens new tab have been making progress in the complicated field of Alzheimer's recently, with Lilly's drug Kisunla getting a recommendation for approval for certain patients from the European Medicines Agency last week. Kisunla is already approved in the U.S. Treatments for Alzheimer's approved so far, including Eisai (4523.T), opens new tab and Biogen's (BIIB.O), opens new tab Leqembi and Lilly's Kisunla, are designed to clear sticky clumps of a protein called amyloid beta in the brain. They carry hefty price tags as well as the risk of serious brain swelling and bleeding.
